FLT3 and leukemia: Consistent with this, 2-deoxy-d-glucose (2-DG) and 3-Bromopyruvate propyl ester (3-BrOP), inhibitors of the glycolytic enzyme hexokinase, were found to synergize with sorafenib in killing leukemia cells with FLT3/ITD mutation [18].